Project Details
Description
Concurrently Controlled, Dose-Escalation Study to Evaluate the Safety and Efficacy of HMI-102 in Adult PKU Subjects with PAH Deficiency
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/22 → 11/1/22 |
Funding
- HOMOLOGY MEDICINES INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.